Sublime

Dallas-based Colossal Biosciences, the self-described de-extinction company behind the woolly mammoth and thylacine, today announced that it is spinning off Form Bio, as an independent software company offering a computational life sciences platform that bridges the gap between data and discovery. 

HOLY SHIT IT'S HAPPENING AI can now write genomes from scratch. Arc Institute an NVIDIA just published Evo-2, the largest AI model for biology, trained on 9.3 trillion DNA base pairs spanning the entire tree of life. it doesn’t just analyze genomes. it creates... See more

Super excited to officially launch our newest product line -- Ginkgo Automation!🤖🧬🤖 Over the past 10 years @Ginkgo has built a ton of amazing technologies from automation to long DNA construction to complex -omics to proprietary data and AI assets. These tools had been kept in-house and only... See more

AI told me the diseases I was at risk of based on modern medical research from my raw genome sequence. Genealogy companies don't provide this data because of FDA regulation risk. o3 went through ~15MB of raw data in 4mins. A country of geniuses in a... See more

I just downloaded 21,690 research papers on Chinese Peptides. Soon to be vectorized and shipped straight to your timeline. https://t.co/fUveFKtzQI

Today, we report Germinal, a method for efficient de novo antibody design, with @santimillef and @SynBioGaoLab. Germinal achieves success rates of 4-22% across diverse epitopes. We make the work fully open, without doing lame things like posting a preprint without methods. 🧵... See more

After 2+ years heads down, I'm thrilled to unveil what I've been building with @aryelipman! @biosphereio, we're unleashing biomanufacturing with a breakthrough UV-sterilized reactor that will slash the cost of producing abundant and sustainable chemicals and food at world scale. We're backed by $8.8m in financing led by @lowercarbon and VXI, with... See more